Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Archives - Dr. Shurin goes to Washington
Dr. Shurin goes to Washington
Date: October 3, 2011
Susan Shurin presides over a $3 billion research budget.
A veteran researcher tells why she’s proud to lead the National Heart, Lung and Blood Institute.
After three decades at Case Western Reserve University, where she conducted extensive research in pediatric hematology-oncology, sickle cell disease, and homeostasis, Susan Shurin ’71 moved East in 2006 to help lead the funding agency that had been supporting much of her work. “There are some things you can do hands on and some things that you can’t affect adequately without being in a leadership position,” she explains of her decision to become deputy director of the NIH’s National Heart, Lung and Blood Institute (NHLBI).
Three years later, when Elizabeth Nadel retired as the NHLBI’s director, Shurin stepped up as acting director—a post she’s now held for two years. “I think I get a longevity award for that,” says Shurin with a chuckle. She chooses not to become a candidate for director but is happy to be an indefatigable steward of the NHLBI’s multifaceted activities and its $3 billion research portfolio.
“I’m extremely proud of the NHLBI portfolio. We have, among other things, transformed cardiovascular disease in this country,” Shurin notes. Citing NHLBI-funded research that has identified risk factors and biological processes such as hypertension and elevated blood lipids, she says, “We’ve been able to develop approaches that have cut the age-adjusted risk of dying of cardiovascular disease in this country by over 50 percent over the last 40 years.” Currently, NHLBI-funded researchers are “looking at better ways of preventing cardiovascular disease in people who have diabetes,” she says.
Shurin also cites the Institute’s leadership in supporting research—much of it at Hopkins—“that has transformed the outcome of sickle cell disease,” which almost always had been fatal; and in treatments for newborns, asthma, chronic pulmonary obstructive disease, and in transfusion medicine practices. “We try to be very strategic in the research that we support,” she says.
Shurin, who joined the staff of Case Western several years after completing her Hopkins residency in 1972, served for 16 years as director of pediatric hematology-oncology at Rainbow Babies and Children’s Hospital, and also served as director of pediatric oncology at the Case Comprehensive Cancer Center. From 2002 to 2004, she was vice president and secretary of the Case Western Reserve Corporation. Her long career in fostering the application of new discoveries to medical treatment earned her the Johns Hopkins University Alumni Association’s Woodrow Wilson Award in 2010 “for distinguished government service.”